Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial

Go back to Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial
(NASDAQ: PXS) Delayed: 4.38 -0.01 (0.23%)
Previous Close $4.39    52 Week High $4.27 
Open $4.37    52 Week Low $0.55 
Day High $4.60    P/E N/A 
Day Low $4.32    EPS $0.00 
Volume 64,967